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Abstract. Electrospray ionization mass spectrometry (ESI-MS) binding studies be-
tween proteins and ligands under native conditions require that instrumental ESI
source conditions are optimized if relative solution-phase equilibrium concentrations
between the protein–ligand complex and free protein are to be retained. Instrumental
ESI source conditions that simultaneously maximize the relative ionization efficiency
of the protein–ligand complex over free protein and minimize the protein–ligand
complex dissociation during the ESI process and the transfer from atmospheric
pressure to vacuum are generally specific for each protein–ligand system and should
be established when an accurate equilibrium dissociation constant (KD) is to be
determined via titration. In this paper, a straightforward and systematic approach for
ESI source optimization is presented. The method uses statistical design of experiments (DOE) in conjunction
with response surface methodology (RSM) and is demonstrated for the complexes between Plasmodium vivax
guanylate kinase (PvGK) and two ligands: 5′-guanosine monophosphate (GMP) and 5′-guanosine diphosphate
(GDP). It was verified that even though the ligands are structurally similar, themost appropriate ESI conditions for
KD determination by titration are different for each.
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Introduction
Binding interactions between ligands and proteins are cru-cial for a wide variety of biological processes and for the
effectiveness of many therapeutic compounds. Among the
methods available for the identification and characterization
of noncovalent interactions between proteins and their ligands,
electrospray ionization mass spectrometry (ESI-MS) offers
advantages of high sensitivity, selectivity, simplicity, and speed
[1–4]. With ESI-MS, native proteins and protein–ligand com-
plexes can be transferred from solution to the gas phase as ions
without changing their relative equilibrium concentrations [5,
6]. ESI-MS can probe specificity and stoichiometry of binding
[7–10], protein conformational changes [11, 12], kinetics [13,
14], thermodynamics of binding [15, 16], and quantify equi-
librium dissociation constants (KD) [17–25]. However, before
establishing any correlation between the relative abundance of
the gas-phase ions in the mass spectra and relative concentra-
tions in solution, differences in ionization and detection effi-
ciencies (response factors) between the free protein and pro-
tein–ligand complex, as well as processes such as nonspecific
ligand binding and protein–ligand complex dissociation, need
to be considered and, if possible, minimized.
To take into account any differences in ionization and
detection efficiencies between the free protein and the pro-
tein–ligand complex, several methods that quantify their re-
sponse factors (R) have been proposed [26–29]. The charge
residue model (CRM) explains that high concentrations of
ligand in the final droplet can lead to nonspecific interactions
between free ligand and free protein, resulting in formation of
nonspecific protein–ligand complexes on droplet evaporation.
These complexes are indistinguishable from specific
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complexes originating from solution in the mass spectra [6,
30]. Based on the observation that nonspecific ligand binding is
independent of the size and structure of the protein and follows
a random distribution (Poisson distribution) [30–34], different
strategies have been developed to correct the ESI mass spectra
for the occurrence of nonspecific ligand binding [33–38].
Although most reports of KD determination by ESI-MS
recognize the importance of adjusting the instrumental source
parameters to preserve the protein–ligand complexes formed in
solution [39–43], none has provided a straightforward statisti-
cal approach for successful systematic ESI source optimization.
Statistical design of experiments (DOE) and response surface
methodology (RSM) have previously been shown to be useful
to optimize signal sensitivity [44–49]. We have, for example,
previously reported the use of a three-level fractional factorial
design to maximize the absolute intensity of the noncovalent
complex bCAII-ethoxzolamide and thus find the best conditions
for screening natural product extracts against this protein [47].
Optimization of the ESI source was performed for the inter-
actions between Plasmodium vivax guanylate kinase (PvGK)
and its natural substrates 5′-guanosine monophosphate (GMP)
and 5′-guanosine diphosphate (GDP). The effects of determined
preselected ESI source parameters on relative ion abundances,
defined as the ratio of protein–ligand complex (1:1 stoichiome-
try) to free protein ion abundances (PL/P), were evaluated in
inscribed central composite designs (CCIs). MS response anal-
ysis by RSM allowed the establishment of optimal ESI source
conditions for KD determination by titration, which was validat-
ed by competition experiments and literature KD values.
Experimental
Materials
GMP and GDP were purchased from Sigma-Aldrich (Castle
Hill, NSW, Australia). Ammonium acetate was purchased
from Fluka (Castle Hill, NSW, Australia). GMP and GDP
stock solutions were prepared in Milli-Q water (Millipore,
North Ryde, NSW, Australia). For protein buffer exchange,
Nalgene NAP-5 size G25, from GE Healthcare, (Parramatta,
NSW, Australia) were used (purchased through Thermo Fisher
Scientific Australia Pty Ltd, Scoresby, VIC, Australia).
Protein Production
Full-length guanylate kinase with an N-terminal 6-histidine tag
(23545 Da) was cloned, produced, and purified as previously
described from Plasmodium vivax cDNA [50].
ESI Source and FT-ICR Mass Spectrometry
All experiments were performed on a Bruker APEX III
4.7 T FT-ICR mass spectrometer equipped with an ex-
ternal Apollo ESI source (Supplementary Figure S1). The
14 experimental ESI source parameters that can be tuned
are: sample flow rate, nebulizer gas (N2) pressure, end
plate voltage, capillary voltage, drying gas (N2) flow
rate, drying gas temperature, capillary exit voltage, skim-
mer 1 and skimmer 2 voltages, trapping and extracting
voltages, and hexapole rf amplitude, hexapole DC offset
voltage, and hexapole accumulation time (Supplementary
Figure S1). All sample solutions were injected manually
using a Cole-Parmer syringe pump. The nebulizer was
off-axis and grounded. The glass capillary was 15 cm in
length and had an internal diameter of 0.5 mm. Between
the capillary exit and the skimmer 1, the background
pressure was ~2 mbar. The ESI source housing, to where
the ions are released after being accumulated inside the
hexapole during a predetermined time, had a pressure of
~2 × 10–6 mbar. The analyzer was an Infinity cell.
PvGK protein was buffer exchanged with 10 mM ammoni-
um acetate buffer (pH 6.8) and stored in aliquots at –28 °C until
needed. For optimization of the ESI source by DOE and RSM,
working solutions of PvGK:GMP (2:4.8 μM) and PvGK:GDP
(2:2.4 μM) were prepared prior to MS analysis by appropriate-
ly diluting the protein (thawed unassisted at room temperature)
and the ligand in 10 mM ammonium acetate buffer (pH 6.8).
For titration experiments, samples with a fixed concentration of
PvGK (2 μM) and varying concentrations of ligand (0–28.8
μM of GMP and 0–7.2 μM of GDP) were prepared. For
competition experiments, samples with a fixed concentration
of PvGK and GMP (2 μM and 9.6 μM, respectively) and
varying concentrations of GDP (0–9.6 μM) were prepared.
Incubation time was 1 h at room temperature (23–25 °C).
The data were acquired in Bruker’s Xmass software. All
spectra were recorded in positive ion mode, with a sum of 32
scans per acquisition and 512 k data points per transient. The
obtained spectra were analyzed in mMass 5.5.0. software. The
protein–ligand complex and free protein ion abundances were
calculated as the sum of all charge states intensity peaks (I)
normalized for charge state (n) (∑ I(PL)n+/n and ∑ I (P)n+/n,
respectively).
Inscribed Central Composite Designs (CCI) for ESI
Source Optimization
Optimization of the ESI source was carried out using
central composite designs (CCD). Inscribed central com-
posite designs (CCI) were chosen because the specified
limits (higher and lower factor levels) corresponded to or
were very close to truly instrumental limits for most of
the selected factors. Each design included a full or frac-
tional factorial portion created within the specified factor
limits (by dividing the distance from the design center to
the factor limits by α), from which the first order or
linear effects could be estimated; a central point, from
which curvature due to two-way interactions or quadratic
terms could be evaluated; and a star portion with exper-
imental points at the specified factor limits, from which
the factors responsible for response surface curvature
could be known. With this type of design, all factors
were studied in five levels. The number of required
experiments was given by 2K-p+ 2K + C, where K is
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the number of factors included in the design, p the
fraction of the full factorial design to be run, and C
the number of replicates at the central point; α values
were dependent on the number of variables and the
desired design characteristics, such as rotatability and
orthogonality. In this study, all CCIs were designed to
be orthogonal and rotatable. All steps of the experimental
design selection, statistical data analysis, and prediction
of optimal factor settings were performed in R software
[51], with the Brsm^ package [52].
KD Determination by Titration
To determine PvGK–GMP and PvGK–GDP KDs by titration,
the relative abundances of bound to total protein in the mass
spectra were correlated to the relative equilibrium concentra-










By plotting experimentally observed ratios between bound
and total protein ion abundances against total concentration of
ligand, KD could be obtained as a parameter of a nonlinear least
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KD Determination by Competition
To determine PvGK–GDP KD by competition, the ion
abundance of the reference protein –ligand complex with
a known binding constant (PvGK–GMP, with KD deter-
mined by titration) was monitored in the presence and in
the absence of the competitor ligand (GDP) and corre-
lated to the corresponding solution equilibrium
concentrations.
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By plotting the observed ratios between the reference
protein –ligand complex in the presence and absence of
competitor ligand as a function of total concentration of
competitor ligand, the KD of the competitor ligand could
be obtained as a parameter of a nonlinear least squares
curve fitting [23]:
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Optimization of PvGK-GMP Complex Over Free
PvGK Ion Abundances
Based on preliminary screening experiments (Supplemen-
tary Figure S2), nine out of the 14 ESI source parame-
ters were selected for statistical optimization. Optimiza-
tion of the ESI source was carried out in two stages
because of the large number of variables. In the first,
sample flow rate (120 to 630 μL/h), drying gas flow rate
(20 to 60 L/min), drying gas temperature (100 to 150
°C) and nebulizer gas pressure (40 to 70 psi) were
studied. In the second, capillary exit voltage (50 to 200
V), skimmer 1 voltage (15 to 25 V), skimmer 2 voltage
(5 to 25 V), capillary voltage (–4000 to –6000 V), and
end plate voltage (–2500 to –3500 V) were studied. It
was assumed that if any interactions between factors
included in the first and second CCI existed, these would
not contribute significantly to the MS response. While
the first stage CCI was carried out in 30 runs (24 + 2 ×
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4 + 6), the second was carried out in 50 runs (25 + 2 ×
5 + 8).
After MS response collection, a second order model
was used to fit the data using the least squares method.
Different MS response transformations were evaluated,
including square root, logarithmic, and squared transfor-
mations. Raw data was chosen last because residuals had
a closer distribution to normality. Supplementary
Tables S1 and S3 provide, for first and second stage
CCI, respectively, the fitted model terms coefficients
and respective statistical significances. Similarly, Supple-
mentary Tables S2 and S4 show the ANOVA employed
to evaluate the quality of the model fitted.
For the first stage CCI, a P-value of 5.82 × 10–9 was
obtained, indicating the model was statistically signifi-
cant. Moreover, the model had an adjusted R2 of 0.94
and a lack of fit P-value of 0.15 (indicating that lack of
fit errors were due to random errors and were not con-
sidered statistically different from pure errors) (Supple-
mentary Table S2). The residuals were normally distrib-
uted and equally dispersed for all predicted values, with
no systematic trends observed. All variables had signifi-
cant main effect on PL/P, with sample flow rate showing
a significant quadratic term and no interaction with any
other parameter (Supplementary Table S1).
Sample flow rate could be tuned independently of the set-
tings of other variables. A threefold increase in sample flow
rate from 120 μL/h up to around 400 μL/h favored PvGK–
GMP complex over free PvGK ion abundances, after which the
tendency was inverted.
Drying gas temperature significantly interacted with
drying gas flow rate. Thus, these parameters needed to
be tuned together. The heated drying gas, N2, flows
counter-current to the charged droplets trajectory and is
very important for desolvation. Lower drying gas tem-
peratures combined with higher drying gas flow rates
provided the best PL/P. The three-dimensional response
surface plots are presented in Figure 1.
According to these results, better PL/P responses could
theoretically be achieved outside the experimental region, es-
pecially if drying gas temperatures less than 100 °C were used
with flow rates in the order of 400–420 μL/h. However, due to
the observed trade-off between the relative ion abundances and
intensities of both free protein and protein–ligand complex,
such combination of factor levels could not be tested or used
in practice. A second order model was also fitted to the signal-
to-noise ratios (S/N) of free PvGK and PvGK–GMP complex
with the only statistically significant interaction being between
drying gas temperature and sample flow rate. The obtained
three-dimensional surface plot for these two variables is shown
in Figure 2 [(a) for PvGK-GMP complex and (b) for free
PvGK]. It is interesting to note that at the lowest drying gas
temperature (100 °C), the S/N of both free PvGK and PvGK–
GMP complex decrease with increasing sample flow rate
(probably due to a decrease in desolvation efficiency). Howev-
er, if enough desolvation energy is provided by increasing the
drying gas temperature, this trend is inverted (S/N increase with
increasing sample flow rates).
Figure 1. Three-dimensional response surface plots of the experimental region studied by first stage CCI, PvGK-GMP system.
Slices of the response surface are displayed for two variables at a time, with other variables fixed at the central point (flow rate 375
μL/h; drying gas flow rate 40 L/min; drying gas temperature 125 °C; nebulizer gas pressure 55 psi). (a) Effect of flow rate and drying
gas flow rate. (b) Effect of flow rate and drying gas temperature. (c) Effect of flow rate and nebulizer gas pressure. (d) Effect of drying
gas flow rate and drying gas temperature. (e) Effect of drying gas flow rate and nebulizer gas pressure. (f) Effect of drying gas
temperature and nebulizer gas pressure
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Experimental verification confirmed that the maximum re-
sponse was obtained at sample flow rate 400 μL/h, drying gas
flow rate 45 L/min, drying gas temperature 105 °C, and nebu-
lizer gas pressure 58 psi.
For the second stage CCI, the regression model was not
significant (P-value of 0.73), even though the fit to the exper-
imental data was good (lack of fit test was nonsignificant with a
P-value of 0.66 and residuals had a normal distribution) (Sup-
plementary Table S4).
Given the nonsignificant impact of capillary exit, skim-
mer 1, skimmer 2, end plate, and capillary voltages on
relative ion abundances, these variables were used to si-
multaneously maximize the S/N of both free PvGK and the
PvGK–GMP complex (1:1 stoichiometry). This approach
involved the construction of a desirability function for each
individual response and their combination by using the
weighted geometric average to obtain an overall desirability
function (R package Bdesirability^ [53]) to establish capil-
lary exit 126.5 V; skimmer 1 15.42 V; skimmer 2 15.55
V; end plate –3085 V; capillary voltage –4033 V. The
improvement in S/N was 76% and 87% for free PvGK
and PvGK-GMP complex, respectively.
The overall optimized conditions for PvGK and the
screening conditions are compared in Table 1. The screen-
ing conditions allowed the observation of protein and pro-
tein–ligand complexes under native conditions, even though
relative solution-phase equilibrium concentrations between
the protein–ligand complex and free protein might not be
preserved. Indeed, the optimized conditions for PvGK-GMP
led to a relative ion abundance of 1.75, whereas screening
conditions gave a relative ion abundance of 0.85.
PvGK–GMP Titration Experiments and KD
Determination
Titration experiments demonstrated that under ESI opti-
mized conditions the relative ion abundances were higher
compared with screening conditions. Representative spec-
tra obtained from samples containing PvGK (2 μM) and
three different concentrations of GMP (2.4, 4.8, and 9.6
Table 1. Optimized and Screening ESI Source Conditions
Optimized conditions Screening conditions
PvGK-GMP system PvGK-GDP system
Sample flow rate (μL/h) 400 145 120
Drying gas flow rate (L/min) 45 38 40
Drying gas temperature (°C) 105 101 125
Nebulizer gas pressure (psi) 58 72 50
Capillary voltage (V) –4033 –5100 –5000
End plate (V) –3085 –3392 –3500
Capillary exit (V) 126.5 200 100
Skimmer 1 (V) 15.42 23.60 24.5
Skimmer 2 (V) 15.55 15.00 24
Hexapole RF amplitude (Hz) 600 600 600
Hexapole DC offset (V) 1.5 1.5 1.5
Hexapole accumulation time (s) 3 3 3
Trapping voltage (V) 23 23 23
Extracting voltage (V) –10 –10 –10
Figure 2. PvGK-GMP complex (1:1 stoichiometry) (a) and free PvGK (b) S/N as a function of flow rate (from 120 to 630 μL/h) and
drying gas temperature (from 100 to 150 °C). The other variables were fixed at the central point (drying gas flow rate 40 L/min;
nebulizer gas pressure 55 psi)
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μM) acquired under both optimized and screening ESI
source conditions are shown and compared in Figure 3.
At GMP concentrations of 9.6 μM and above, nonspecific
protein–ligand binding was detected. The model developed
by Daubenfeld et al. [37] was used to separate specific and
nonspecific binding. The plot of the fraction of bound pro-
tein ([PL]/[P]t) versus total concentration of GMP and the
best curve fit is shown in Figure 4. The KD obtained after
nonlinear least squares curve fitting using Equation (2) was
1.84 ± 0.11 μM and 3.67 ± 0.30 μM, respectively, for ESI
source optimized and screening conditions.
The KD obtained under ESI source optimized conditions for
PvGK–GMP was in good agreement with the results obtained
for GMP binding to Plasmodium falciparum guanylate kinase
(1.45 ± 0.05 μM at 25 °C, determined by isothermal titration
calorimetry) [54]. By contrast, the KD determined under
screening conditions was an overestimate.
Competition Experiments for PvGK-GDP KD
Determination
Competition experiments revealed a clear competition
between GMP and GDP for protein binding (Figure 5).
Figure 3. PvGK-GMP titration experiments: representative spectra obtained from samples containing 2 μM PvGK and three of the
increasing concentrations of GMP [2.4 μM in (c), 4.8 μM in (b) and 9.6 μM in (a)] acquired under ESI source optimized (2) and
screening conditions (1)
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As the concentration of GDP was increased in solution
GMP was proportionally displaced from the protein, as
can be observed from the decrease of PvGK–GMP and
increase of PvGK-GDP complexes in Figure 5a and the
linear relationship between the ratio of their ion abun-
dances and total GDP concentration in Figure 5c. The
degree of GMP displacement from the protein due to the
presence of GDP was used to quantitatively estimate
GDP KD (Figure 5b). The GDP KD was estimated to
be 0.31 ± 0.07μM. Given GDP has one more phosphate
group compared with GMP, it contains more possibilities
for electrostatic/Coulombic interactions with the protein
and, thus, for binding more tightly. To cross-validate the
ESI source optimization approach, this was independently
optimized for the PvGK–GDP system. The KD deter-
mined by titration thereafter was compared with the KD
determined by competition.
Figure 4. Fraction of bound protein ([PL]/[P]t) obtained under
both ESI optimized and screening (pre-optimized) conditions
plotted against total ligand concentration, GMP. The curves of
best fit using the method of least squares with Equation (2) are
present
Figure 5. Competiton experiments: spectra obtained from samples containing 2 μM PvGK, 9.6 μM GMP, and increasing concen-
trations of GDP [(0 μM in 1), (1.2 μM in 2), (2.4 μM in 3), (4.8 μM in 4), and (9.6 μM in 5)] are shown in (a). Reference protein–ligand
complex [PvGK:GMP (2:9.6 μM)] concentration in the presence of competitor ligand (GDP) over reference protein–ligand complex
concentration in the absence of competitor ligand is plotted as a function of total concentration of GDP in (b). The solid line
represents the best fit obtained using Equation (4). The linear relationship between the ion abundances of PvGK-GDP complex over
PvGK-GMP complex and total GDP concentration is shown in (c)
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Optimization of PvGK-GDP Complex Over Free
PvGK Ion Abundances
Optimization of the ESI source for the PvGK–GDP systemwas
carried out in two stages; in the first, sample flow rate (120 to
630 μL/h), drying gas flow rate (20 to 60 L/min), drying gas
temperature (100 to 150 °C), and nebulizer gas pressure (30 to
80 psi) were studied. In the second, capillary exit voltage (50 to
200 V), skimmer 1 voltage (15 to 25 V), skimmer 2 voltage (5
to 25 V), capillary voltage (–4000 to –7000 V), and end plate
voltage (–2500 to –3500 V) were studied.
The coefficients of the second-order model estimated with
the raw MS responses of the first stage CCI is shown in
Supplementary Table S5. Its ANOVA table (Supplementary
Table S6) shows that the model was statistically significant (P-
value 2.00 × 10–9), presenting an adjusted R2 of 0.85 and
nonsignificant lack of fit (P-value 0.08). All variables except
drying gas flow rate had significant main effect on PL/P.
Similarly to the PvGK–GMP system, sample flow rate had a
significant quadratic term and a significant interaction with
nebulizer gas pressure. Drying gas flow rate and drying gas
temperature did not influence PL/P significantly. Confirmation
experiments conducted at specified distances from the design
center (0, 0.5, 1, 1.5) verified that maximum PL/P response
could be obtained at sample flow rate 145 μL/h, drying gas
Figure 6. Three-dimensional response surface plots of skimmer 1 versus capillary exit (a) and capillary versus end plate voltages (b)
(second stage CCI, PvGK-GDP system). Other variables are fixed at the central point (skimmer 1, 20 V; skimmer 2, 15 V; end plate –
3500 V; capillary voltage –5500 V; capillary exit 125 V)
Scheme 1. Summary of ESI source parameters studied by statistical DOE and RSM and their influence on relative ion abundances
for (a) PvGK-GMP system and (b) PvGK-GDP system: parameters inside white boxes had no significant impact on relative ion
abundances; parameters inside colored boxes had significant main effect on relative ion abundances; connecting lines denote
significant interactions or quadratic effects
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flow rate 38 L/min, drying gas temperature 101 °C, and nebu-
lizer gas pressure 72 psi.
For the second-stage CCI, the ANOVA demonstrates that the
regression model estimated with the raw MS responses was
statistically significant (P-value 2.27 × 10–4), presenting an ad-
justed R2 of 0.32 and nonsignificant lack of fit (P-value 0.17)
(Supplementary Table S8). Contrary to what was observed for the
PvGK–GMP system, capillary exit had a significant main effect,
as did its interaction with skimmer 1 (Supplementary Table S7).
At lower skimmer 1 settings, an increase in capillary exit promot-
ed a decrease in relative ion abundances, whereas at higher
skimmer 1 values, an increase in capillary exit increased consid-
erably relative ion abundances (Figure 6a). A similar effect was
observed for a statistically significant interaction between end
plate and capillary voltages (Figure 6b). For the PvGK–GDP
system no trade-off between relative ion abundances and S/N of
both freePvGK andPvGK-GDP complex was found.We believe
that the additional phosphate group of GDP contributes to the
increased stability of the protein–ligand complex, thus tolerating
higher voltages, which improve the declustering efficiency with-
out promoting the complex dissociation. Experimental results
confirmed that the maximum response could be obtained at
capillary –5100 V, end plate –3392 V, capillary exit 200 V,
skimmer 1, 23.60 V, and skimmer 2, 15.00 V. The overall
optimized and screening conditions are compared in Table 1.
PvGK–GDP Titration Experiments and KD
Determination
The KD determined after nonlinear least squares curve fitting
using Equation (2) was 0.30 ± 0.03 μM. The KD was in
excellent agreement with the KD found by competition exper-
iments (0.31 ± 0.07 μM). These results confirm the value of
ESI source optimization by statistical DOE and RSM in order
to improve the accuracy of KD determinations by ESI-MS.
Conclusions
A systematic approach, combining statistical DOE with RSM,
simultaneously maximizes the relative ionization efficiency of
a protein–ligand complex over free protein, minimizes the
dissociation of protein–ligand complex and enables the estab-
lishment of appropriate ESI source settings for KD determina-
tion by titration. If the fractional protein occupancy tends to one
as ligand concentrations are increased, KD can directly be
determined by nonlinear least squares curve fitting using Equa-
tion (2). However, if nonspecific ligand binding is observed,
this needs to be considered before KD determination. In this
study, the model introduced by Daubenfeld et al. [37], which
explains ligand binding as a convolution of two different
statistical distributions (a binomial distribution for specific
ligand binding and a Poisson distribution for nonspecific ligand
binding), was used to compute the contributions from only
specific ligand binding. If the fractional protein occupancy
does not tend to one even after ESI source optimization, we
propose that the horizontal asymptote on the right side is
determined and used to correct the experimental data, in a
similar way presented by Jaquillard et al. [25]. Here, the as-
sumption that protein–ligand complex dissociation is only
dependent on its gas-phase stability under vacuum and thus
the type of intermolecular interactions involved in binding is
made. Hence, a constant correction factor can be applied to the
experimental fraction of bound protein obtained over the range
of ligand concentrations used for the titration experiment.
The optimization was demonstrated for the noncovalent inter-
actions between PvGK and its natural substrates GMP and GDP.
The results show that the ESI conditions, which better retain
relative solution-phase equilibrium concentrations between a pro-
tein–ligand complex and free protein, depend on the protein–
ligand system itself (Scheme 1). These results also showed that
if ESI source instrumental conditions are carefully chosen, the
accuracy of KD determinations by ESI-MS can be improved.
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